Femdophilus contains two patented probiotic strains, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, discovered and developed to colonize and protect the vaginal tract. Get the protection you need with one capsule daily for maintenance or increase to 2 capsules a day as needed.
Patented Strains Lactobacillus Rhamnosus GR-1® and Lactobacillus Reuteri RC-14®
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.*
Serving Size 1 Capsule
Amount Per Serving
Total Probiotic Blend
5 Billion viable cells
Composed of the following strains:
Lactobacillus rhamnosus, GR-1®†
Lactobacillus reuteri, RC-14®†
* Daily Value not established.
Other Ingredients: Dextrose anhydrate, potato starch, cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.
Contains: Dairy (casein, in trace amounts).
No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no nuts/tree nuts.
USAGE: For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.
Keep out of the reach of children.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
5 Billion viable cells per capsule when kept refrigerated and within Best Used Before Date.
RC-14® and GR-1® are Trademarks of Chr. Hansen A/S.
†Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.